Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacokinetics, Target Engagement of an Immunoproteasome Subunit Low-Molecular-Mass Polypeptide‑2 (LMP2) Inhibitor AR-01, and Its Anti-Alzheimer's Effects in Rodents.

ACS pharmacology & translational science·2026
Same author

Immunoproteasome inhibition protects the retina from Alzheimer's-associated degeneration.

BMB reports·2026
Same author

Performance of a quality control center supporting national antimicrobial resistance surveillance.

British journal of biomedical science·2026
Same author

Metformin Activates AMP-Activated Protein Kinase-Transcription Factor EB Signaling to Restore Lysosomal and Mitochondrial Homeostasis and Suppress Epithelial-to-Mesenchymal Transition in Oxidative Stress-Injured Retinal Pigment Epithelium.

The American journal of pathology·2026
Same author

Rapid and sensitive detection of bla<sub>KPC</sub> and bla<sub>NDM</sub> in carbapenemase-producing Enterobacterales using a one-pot recombinase polymerase amplification-CRISPR/Cas12a system with modified protospacer adjacent motifs.

Biosensors & bioelectronics·2026
Same author

Preoperative Prediction of Prolonged Operative Time in Laparoscopic Ovarian Cystectomy Using Convolutional Neural Network-Extracted Ultrasound Image Features.

Journal of minimally invasive gynecology·2026

Related Experiment Video

Updated: Jun 19, 2026

Assays for the Identification of Novel Antivirals against Bluetongue Virus
12:02

Assays for the Identification of Novel Antivirals against Bluetongue Virus

Published on: October 11, 2013

14.5K

Discovery of a Potent Tat-Binding Antiretroviral Compound Using a Two-Step Screening Approach.

YoungHyun Shin1, Yujin Jung2, Dong-Eun Kim1

  • 1Division of Chronic Viral Disease, Center for Emerging Virus Research, National Institute of Health, 187 Osongsaengmyeong 2-ro, Cheongju 28159, Republic of Korea.

Biochemistry
|November 28, 2025
PubMed
Summary

Researchers identified a novel 2-phenyl acrylate compound that inhibits HIV-1 Tat-mediated transcription. This discovery offers a new antiretroviral strategy by targeting a distinct step in viral replication.

More Related Videos

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
11:34

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

Published on: May 5, 2014

14.3K
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

18.3K

Related Experiment Videos

Last Updated: Jun 19, 2026

Assays for the Identification of Novel Antivirals against Bluetongue Virus
12:02

Assays for the Identification of Novel Antivirals against Bluetongue Virus

Published on: October 11, 2013

14.5K
High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
11:34

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses

Published on: May 5, 2014

14.3K
Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

18.3K

Area of Science:

  • Virology
  • Molecular Biology
  • Drug Discovery

Background:

  • HIV-1 transcription relies on the viral transactivator Tat.
  • Targeting Tat-mediated transcription is a promising antiretroviral strategy.
  • Specificity challenges exist due to potential off-target effects.

Purpose of the Study:

  • To identify selective inhibitors of Tat-mediated HIV-1 transcription.
  • To develop novel antiretroviral compounds targeting a distinct viral replication step.

Main Methods:

  • Two-step screening using TR-FRET and dual-luciferase reporter assays.
  • Biophysical methods including surface plasmon resonance.
  • Functional assays like time-of-addition and coimmunoprecipitation.

Main Results:

  • Identified 655 initial hits, with 46 compounds meeting selection criteria.
  • Methyl (E)-2-(2-((4-(decyloxy)phenoxy)methyl)phenyl)-3-methoxyacrylate showed high potency (IC50/EC50 ~1 μM).
  • The compound binds Tat peptide, inhibits Tat-dependent transcription, and does not degrade Tat or disrupt Tat/CycT1 complex.

Conclusions:

  • A novel 2-phenyl acrylate derivative selectively inhibits Tat-mediated HIV-1 transcription.
  • This compound represents a promising lead for developing new antiretroviral therapies.
  • The integrated screening strategy successfully identified a Tat-centric inhibitor.